Search results for: 'da1a 2 drug grid coat'
- Did you mean
- disa 2 drug grid coat
- dawn 2 drug grid coat
- Related search terms
- da1a 01 00 00 00
- drug 01 00 00 00
- grid integration building solutions market global 2024 2030
- grid integration building solutions market global 2024 2020
- grid integration building solutions market global 2020 2024
-
22 Jan 2015  |  North America  |  Market Research
A Product and Pipeline Analysis of the Antibacterial Drugs Market
Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D
Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...
$3,950.00
Special Price $2,962.50 save 25 %
-
16 Dec 2015  |  North America  |  Market Research
Analysis of Wood Coatings Market in NA and Europe
Rebound of the Residential Construction Market and Stringent Environmental Regulations will Accelerate Growth
This research service analyzes the European and North American market for wood coatings and resins. The product segments covered are wood coatings by regions, technologies (solvent-borne, waterborne and UV-cured), applications (siding; decking; flooring; doors and windows; furniture and kitchen cabinetry) and resin chemistries (acrylic, polyurethan...
$6,000.00
Special Price $4,500.00 save 25 %
-
18 Nov 2015  |  North America  |  Market Research
North American Flexible Packaging Coatings for the Food and the Pharmaceuticals Markets
The Desire to Reduce Food Wastage and the Regulatory Developments Steer Growth
This research service identifies the major market drivers and restraints and the regulatory and technology trends affecting the North American flexible packaging coatings market in the food and the pharmaceutical industries. The product segments covered in this study are heat seal coatings, cold seal coatings, barrier coatings, co-extrusion primers...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 May 2017  |  North America  |  Market Research
Global Antimicrobial Coating Materials Market for Medical Devices, Forecast to 2021
Growing End Application Demand Induced by Rising Awareness
The rise in the global population suffering from cardiovascular diseases and other lifestyle-associated illnesses is slated to increase the need for surgery. This, combined with the growing incidence of nosocomial infection across hospitals, is expected to stimulate antimicrobial coating materials demand. The escalating birth rate will augment the ...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Feb 2024  |  North America  |  Market Research
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services
M&As, Partnerships, and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Jan 2017  |  North America  |  Market Research
North American and European Architectural Coatings Market, Forecast to 2023
Changes in Customer Preferences, Regulatory Rules, and Product Advancements will Boost Market Growth
Scope of the Study This research study includes the following segments: Scope: Architectural coatings. Segmented by chemistry (acrylics, alkyds, polyurethanes, others) and segmented by technology (waterborne, solvent-borne) Geographic scope: North America and Europe End-user scope: Architectural coating manufacturers, coating manufacturers, profe...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 May 2013  |  North America  |  Market Research
Analysis of the North American Oral Solid Drug Dosage Excipients Market
Blockbuster Drug Patent Expiration Expected to Boost Market Growth
Excipients are used to support the delivery of the APIs (active pharmaceutical ingredients) through oral dosage, parenteral, and transdermal medications. For oral dosages, the key delivery forms are tablets and capsules. This research service covers the North American oral solid drug dosage excipients market. Based on functionality, excipients are ...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Nov 2016  |  North America  |  Market Research
Global Orphan Drug Market
High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs
The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...
$6,000.00
Special Price $4,500.00 save 25 %
-
29 Dec 2017  |  North America  |  Technology Research
Innovations in Transdermal Drug Delivery
Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry
With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %